← All trials
NCT04852185
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 5, 2021
- Primary completion
- Dec 31, 2024
- Completion date
- Dec 31, 2024
- First posted
- Apr 21, 2021
- Last posted
- Apr 21, 2021
- Enrollment
- 23000
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- International Vaccine InstituteLead sponsor
- International Center for Diarrheal Disease ResearchCollaborator
- University of CambridgeCollaborator
- Fondation MérieuxCollaborator
- University of MarylandCollaborator
- Kwame Nkrumah University of Science and TechnologyCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.